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Friend virus induces massive splenomegaly and erythroblastosis in susceptible mice 
(1, 2). Certain strains of Friend virus, designated FV-P  1 for polycythemia (3), cause 
the rapid accumulation of erythroid precursors that can differentiate in vivo (4, 5) 
and in vitro (6, 7) in the absence of erythropoietin. Mice infected with these strains of 
Friend virus experience a  tremendous increase in the rate of erythropoiesis (8)  and 
become polycythemic. The component of Friend virus stocks that is thought to be 
responsible for inducing polycythemia is a  replication-defective virus called spleen 
focus-forming virus (SFFV; 9-11). Understanding the mechanism of FV-P-stimulated, 
erythropoietin-independent erythropoiesis should provide fundamental insights into 
erythroid differentiation and viral leukemogenesis. 
Mouse strains that carry the Fv-2 r allele (12) are strongly resistant to Friend virus- 
stimulated  erythropoiesis  (13,  14). The  mechanism  of this  resistance  is  not  well 
understood. On the one hand, Fv-2 controls the replication of SFFV in vivo (13) and 
in long-term bone marrow cultures (15), although not in fibroblasts (16).  Restricted 
replication of SFFV  in  Fv-2 ~ mice could explain their relative resistance to virus- 
stimulated erythropoiesis. On the other hand, the Fv-2 gene also plays a role in normal 
erythropoiesis, controlling the proportion of early erythroid precursors synthesizing 
DNA  (17),  and  regulating the expression  of virus-related  RNA  (18) and  a  virus- 
related differentiation antigen in uninfected hemopoietic cells (19). These pleiotropic 
effects of Fv-2 on normal erythropoiesis could also be related to the mechanism of 
resistance  to  virus-stimulated  erythropoiesis.  The  experiments  reported  here  were 
designed to investigate whether Fv-2 ~ restriction of SFFV replication, or some other 
effect of the Fv-2 ~ gene, is responsible for resistance of Fv-2 ~ mice to Friend virus- 
stimulated erythropoiesis. 
In  these experiments, bone marrow chimeras containing mixtures of Fv-2 ~  and 
Fv-288 bone marrow were constructed. The bone marrow donors were chosen to differ 
in hemoglobin type so that the proportion oferythrocytes derived from each donor in 
the chimera could be determined by hemoglobin electrophoresis. These chimeric mice 
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were infected with  FV-P, and  the effect of the virus on erythropoiesis derived from 
each donor marrow was determined at various times after infection. 
Previous  experiments  have  shown  that  Fv-2  phenotype  is  determined  by  the 
transplanted bone marrow cells in radiation chimeras. Thus, transplantation of Fv-28s 
bone marrow into lethally irradiated Fv-2 '~ mice renders them susceptible to Friend 
virus, whereas transplantation of Fv-2 rr bone marrow into Fv-2 ss mice renders them 
resistant  (14,  20).  Radiation chimeras containing mixtures of F v-2 ~  and Fv-2 ~  bone 
marrow are susceptible to Friend virus as determined by spleen focus formation (14), 
as  are  F1  mice  of Fv-2 '~  ×  Fv-2 ~  crosses.  Because  spleen  foci  are  associated with 
proliferating ~:ells of the erythroid lineage (9), it seemed likely that chimeras containing 
mixtures of Fv-2 '~ and Fv-2 ~  bone marrow would be susceptible to virus-stimulated 
erythropoiesis. 
The  experimental  results  show  that  chimeras  containing  mixtures  of Fv-2 ~  and 
Fv-2 s` bone marrow are indeed susceptible to virus-stimulated erythropoiesis, but that 
the Fv-2 '~ bone marrow maintains its resistance in the chimeras. Because both bone 
marrows are exposed to the same amount of SFFV in these mice, the results indicate 
that  Fv-2 ~  bone  marrow  is  resistant  to  virus-stimulated  erythropoiesis even  when 
exposed  to  an  amount  of SFFV sufficient  to  stimulate Fv-2 ~  erythroid precursors. 
This implies that Fv-2 ~r mice are resistant to virus-stimulated erythropoiesis for reasons 
other than poor replication of SFFV. 
Materials and Methods 
Mice.  DBA/2, B10.D2, and (C57BL/10 ×  DBA/2)FI (BDF1) mice were obtained from the 
Imperial Cancer Research Fund Laboratories. 
Virus.  NB-tropic  (21)  FV-P  was  a  gift  from  F.  Lilly  (Department  of Genetics,  Albert 
Einstein College of Medicine)  and  was routinely passaged as a  10%  spleen homogenate  in 
DBA/2 or BDFx mice. This virus gave approximately equal spleen focus-forming titers (9) in 
DBA/2 and BDF1 mice. 
Radiation Chimeras.  3-5-mo-old male DBA/2 or female B10.D2 mice were exposed to 1,000 
:1:50 rad (240 kV,  14.5 mA, 130 rad/min,  18" from x-ray source to target). Immediately after 
irradiation, mice were transfused through the tail vein with 7 ×  10  e bone marrow cells from 
DBA/2  donors,  B10.D2  donors,  or  mixtures  of bone  marrow  cells  from  the  two  donors. 
Irradiated controls that  were not transfused with bone marrow all died within 2 wk.  Mice 
transplanted with viable bone marrow cells had a  survival of ~85% at  1 mo with sporadic 
deaths for 4-6 mo thereafter, at which time the experiments were terminated. 
Phenylhydrazine (PHZ)  Treatment.  Mice were injected with 0.8 mg of PHZ intraperitoneally 
or subcutaneously  at  the  indicated times  after bone  marrow  transplantation  and/or  virus 
infection. 
Routine  Hematology.  Mice were bled from the tail vein. Hematoerits were measured using 
heparinized microhematocrit tubes.  Reticulocytes were stained with  1% brilliant cresyl blue 
(22). 
Hemoglobin  Electrophoresis.  Erythrocytes were washed three times with  normal saline and 
lysed in  15  vol of solution containing 67 mM cystamine d~ydrochloride (Aldrich Chemical 
Co., Inc., Milwaukee, Wis.), 103 mM dithiothreitol, and 0.25% NH3OH (23). Membranes were 
removed by centrifugation. Hemolysates were electrophoresed for 2-4 h at 225 V on cellulose 
acetate strips (Shandon "cellogram" [Shandon Southern Iristruments, Inc., Sewickley, Pa.] or 
Whatman "celloger' [Whatman, Inc., Clifton, N. J.]) using a buffer containing 180 mM Tris, 
100 mM boric acid, and 2 mM EDTA, pH 8.9.  Some gels were stained with 1% Ponceau S in 
45% methanol-5% acetic acid and destained in 5% acetic acid. Other gels were air dried and 
autoradiographed using Kodak XR-5 film (Eastman Kodak Co., Rochester, N. Y.). 
~gFe Labeling.  Intact mice were injected intravenously or intraperitoneally with 1-10/xCi of 
freshly buffered SgFec13 (2-20 ~Ci//xg; Amersham Corp., Arlington Heights, Ill.) and bled 2 d 128  FRIEND VIRUS-STIMULATED ERYTHROPOIESIS 
later. In some experiments, reticulocytes were labeled in vitro by adding 20 #1 of whole blood 
to a solution containing 0.45 ml dialyzed fetal calf  serum, 0.45 ml a medium (Flow Laboratories, 
Inc., Rockville, Md.), and 0.1 ml (5 #Ci) of freshly buffered 59FeCI3. The mixture was incubated 
at 37°C for 2-8 h. Radiolabele'd erythrocytes were washed three to six times with Dulbecco's 
modified Eagle's medium to remove excess label and then prepared for hemoglobin electropho- 
resis as above. Hemolysates were kept at 4°C and electrophoresed within 12 h. 
Quantitation of  the Relative Amount of  Each Hemoglobin Type.  Individual hemoglobin bands were 
cut from the cellulose acetate strips and eluted in  1 ml of distilled H~O. Absorbance of each 
eluate was measured spectrophotometrically at 415 nm. The relative amount of each hemoglo- 
bin type in a mixture was calculated as the ratio of absorbance of the eluate from that band to 
the  total  hemoglobin  absorbance  (24).  Radioactivity was  measured  in  a  Beckman  liquid 
scintillation counter  (Beckman  Instruments,  Inc.,  Fullerton, Calif.). The relative amount  of 
newly synthesized hemoglobin of each type was calculated as the ratio of dpm in the eluate 
from a  particular hemoglobin band to the total dpm from all hemoglobin bands. Aliquots of 
5-60 #1 of hemolysate were used for each sample (applied as a linear streak 5 #l/cm) so that the 
total number of hemoglobin-associated dpm was about 2,000  per sample. 
Statistics.  The proportion of total or newly synthesized hemoglobin of a  given type was 
determined for each mouse. These values were averaged for mice within each group. Statistical 
significance was calculated using the two-tailed Student's t test. 
Results 
DBA/2  and  B10.D2  mice were chosen to make the chimeras because, in addition 
to differing at Fv-2 and hemoglobin (Hbb) loci, these strains are identical at H-2, the 
major histocompatibility locus;  both  strains have  the H-2 a haplotype. H-2 identity 
was  important  in  order to minimize graft-vs.-host or "graft-vs.-graft" disease in  the 
chimeras.  B10.D2  mice  are  resistant  to  Friend  virus  at  Fv-2  (Fv-2  '~)  and  have  the 
"single" hemoglobin type, HbbS';  DBA/2 mice are susceptible to Friend virus at Fv-2 
(Fv-2  ~) and have the "diffuse" hemoglobin type, Hbb aa. 
The  hemoglobins  of BI0.D2  and  DBA/2  mice  can  be  clearly  distinguished  by 
eleetrophoresis (23) as shown in Fig.  1. The proportion of each type of hemoglobin in 
a  mixture  can  be analyzed quantitatively by electrophoresis followed by elution of 
hemoglobin  bands  and  measurement  of  absorption  at  415  nm,  as  described  in 
Materials  and  Methods.  For  mixtures  containing  at  least  15%  of either  type  of 
hemoglobin, this method gave reproducible results to within 5%  (data not shown). 
To  measure  the  relative  amounts  of newly  synthesized  hemoglobin  of different 
types  in  a  mixture,  reticulocytes  were  labeled  in  vivo  or  in  vitro  with  59Fe  (see 
Materials and Methods). Hemolysates were then electrophoresed and the dpm of 59Fe 
in the various hemoglobin bands were compared. This method of measuring relative 
FIG.  1.  Cellulose acetate electrophoresis of hemoglobins from DBA/2 and B 10.D2 mice. Hemoly- 
sates were prepared from mixtures of whole blood from normal DBA/2 and B10.D2 mice, mixed in 
the ratios: (a)  100% DBA/2;  (b) 80% DBA/2:20% B10.D2; (e) 60% DBA/2:40% B10.D2; (d) 40% 
DBA/2:60% B10.D2; (e) 20% DBA/2:80% B10.D2; and (f)  100% B10.D2. The electrophoretogram 
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amounts of newly synthesized hemoglobin of different types is very simple, but has a 
potential disadvantage.  If there were a significant iron exchange between hemoglobin 
molecules  in  a  hemolysate  (25),  one  could  not  use  the  proportion  of 59Fe  in  one 
hemoglobin band to measure its relative synthesis rate. To test whether iron exchange 
would pose a  problem, the following control experiments were done. 
In one set of experiments,  59Fe-labeled erythrocytes of each hemoglobin type were 
mixed with unlabeled erythrocytes of the other hemoglobin type. The mixtures were 
hemolyzed and electrophoresed after incubation for various times.  It was found that 
hemolysates kept at 4°C and electrophoresed within  12 h showed <10% incorporation 
of radioactivity  into  the originally  unlabeled  hemoglobin  type.  Longer incubations 
and higher temperatures  resulted  in greater transfer of label.  Therefore, to minimize 
iron exchange, hemolysates were kept cold and electrophoresed within  12 h. 
A  more  physiological  control  experiment  is  shown  in  Fig.  2.  DBA/2  mice  were 
lethally  irradiated  (1,000  _+ 50 rad)  and  transfused  with  7  ×  106 bone marrow cells 
from DBA/2 donors, B 10.D2 donors, or a  1:1 mixture of bone marrow cells from the 
two strains.  1 mo after transplantation,  the recipients were injected with  1 #Ci of 59Fe 
intravenously and bled 2 d later. Because mouse erythrocytes have a life span of about 
50  d  (26),  at  1  mo  after  bone  marrow  transplantation,  approximately  half of the 
circulating erythrocytes should  be of recipient  type, having been  formed before  the 
transplant,  whereas the remaining erythrocytes should be of donor type, having been 
synthesized  after  the  transplant.  The  upper  panel  of Fig.  2  shows  that  mice trans- 
planted  with  B10.D2  bone  marrow  had  ~50%  DBA/2-type  hemoglobin  and  50% 
B10.D2-type hemoglobin, whereas  mice that  received  a  1:1  mixture  of B10.D2  and 
DBA/2  bone  marrow  had  ~75%  DBA/2-type  hemoglobin  and  25%  B10.D2-type 
hemoglobin,  as expected.  The  lower panel  of Fig.  2  is an  autoradiogram  of the gel 
Fro.  2.  Cellulose acetate electrophoresis of hemoglobin from chimeras labeled in vivo 1 mo after 
bone marrow transplantation.  DBA/2 mice were lethally irradiated and transplanted with DBA/2 
bone marrow (lanes a and b), B10.D2 bone marrow (lanes e and 0, or a 1:1 mixture of DBA/2 plus 
B 10.D2 bone marrow (lanes c and d).  1 mo later, each mouse received I #Ci of ~°Fe intravenously. 
The  upper  panel  shows a  photograph  of a  Ponceau S-stained gel. The  lower panel  shows an 
autoradiograph  of the same gel before Ponceau S staining. Each lane contains hemoglobin from a 
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shown in the upper panel. It demonstrates clearly that only the donor-type hemoglobin 
is radioactive, despite the presence of up to 50% unlabeled recipient-type hemoglobin 
in the sample. This experiment shows that one can selectively label newly synthesized 
hemoglobin with 59Fe in chimeras containing both types of hemoglobin. Because iron 
exchange  between  labeled  and  unlabeled  hemoglobin  molecules  did  not occur to a 
significant  extent,  the  method  was  deemed  adequate  to  measure  relative  rates  of 
synthesis of different hemoglobin types in chimeras infected with FV-P. 
Stability  of Hemoglobin Type in  Radiation  Chimeras.  Several  groups  of DBA/2  and 
B10.D2 mice were lethally  irradiated  and transfused  with  DBA/2, B10.D2, or a  1:1 
mixture of DBA/2 and B 10.D2 bone marrow. Blood samples were analyzed from 2 to 
4  mo after  transplantation  to  determine  the  proportion  of hemoglobin  of the  two 
types.  Mice  that  were  transplanted  with  allogeneic  bone  marrow  never  showed 
detectable  amounts  of syngeneic  hemoglobin.  Mice  that  received  1:1  mixtures  of 
DBA/2 and  B10.D2 bone marrow contained  mixtures  of the two hemoglobin types, 
usually in the range of 30-50% B 10.D2 hemoglobin and 70-50% DBA/2 hemoglobin. 
The reason for the slight predominance of DBA/2 hemoglobin in the chimeras is not 
known.  Because  it  occurred  in  both  B10.D2  and  DBA/2  recipients,  it  does  not 
represent  recovery of endogenous bone marrow.  In a  few mice followed serially from 
2  to  4  mo  after  transplantation,  there  was  a  slight  increase  in  the  proportion  of 
DBA/2  hemoglobin  with  time,  on the order of ~5%  more DBA/2  hemoglobin  per 
month. This could represent a proliferative advantage of DBA/2 erythroid precursors, 
or preferential  destruction  of B10.D2 erythroid precursors or erythrocytes. It should 
be  noted  that  B10.D2  and  DBA/2  mice  differ  at  several  minor  histocompatibility 
loci, including erythrocyte antigens  (27).  A  Coombs test was done to investigate the 
possibility  of immune  erythrocyte  destruction;  no  Coombs-positive  chimeras  were 
found. 
Effect  of FV-P on  Hemoglobin Synthesis in  Radiation  Chimeras.  Groups  of chimeras 
containing mixtures  of B10.D2  and  DBA/2  bone marrow were  infected  with  1,000 
focus-forming  units  (FFU)  of FV-P  and  examined  for  type  of hemoglobin  being 
synthesized  1 mo later.  As shown  in  Fig.  3,  infected  chimeras  stopped  synthesizing 
B10.D2 hemoglobin, whereas control chimeras continued to synthesize both types of 
hemoglobin. This result was independent  of whether the irradiated  host was DBA/2 
or BI0.D2. 
Quantitative  results  from  this  experiment  are  shown  in  Table  I.  In  uninfected 
Fla.  3.  Autoradiograph of hemoglobin electrophoresis from mice labeled in vivo with 10 ~Ci ~Fe. 
Lane a: BDF1 control. Lanes b-g: BI0.D2 mice lethally irradiated  and transplanted  with a  1:1 
mixture of B  10.D2 and DBA/2 bone marrow 4 mo earlier. Lanes b-d: chimeras infected with 1,000 
FFU  of FV-P  1 mo earlier;  lanes e-g: uninfected chimeras. Lanes h-m:  DBA/2  mice lethally 
irradiated and transplanted with a  1:1 mixture of DBA/2 and B10.D2 bone marrow 4 mo earlier; 
lanes h-j: uninfected chimeras; lanes k-m: chimeras infected with 1,000 FFU of FV-P 1 mo earlier. 
Each lane contains hemoglobin from a different mouse. Arrow indicates Hbb  8  band. J.  SILVER AND N.  TEICH 
TABLE  I 
Effect of Friend  Virus Infection on Synthesis of Hbb* in Bone Marrow Chimeras 
131 
Number of  Reticulo-  Total hemo-  Newly syn-  the.sized he-  Treatment group  mice  Hematocrits  cytes  globin  moglobin 
%  %  % Hbb 8  % Hbb ~ 
I.  B10.D2 chimeras  3  48:1:4  6:1:1  38 ±  7  36 :t: 7 
II. BI0.D2 chimeras + FV-P  3  54 -t- 5*  12 -4- 6  28:1:10  8 :t: 1:~ 
III. DBA/2 chimeras  3  43:1:2  4:1:1  28:1:7  22 :lz 6 
IV.  DBA/2 chimeras + FV-P  3  53 :l: 11  10 :t: 7  19 :k 1  9:1: 1§ 
Mice were lethally irradiated and transplanted with a 1:1 mixture of DBA/2 and B 10.D2 bone marrow 
cells 3 mo before the start of the experiment. On day 0, mice in groups II and IV were inoculated with 
1,000 FFU of Friend virus intravenously. All mice received 10 #Ci of ~Fe intravenously on day 25 and 
were bled 2 d later. Numbers in the table are mean :t= SD of values determined on day 27, unless otherwise 
indicated. 
* Hematocrits on day 17 after infection. 
:]: P < 0.001 compared with control group. 
§ P < 0.02 compared with control group. 
B10.D2  chimeras,  36%  of newly  synthesized  and  38%  of total  hemoglobin  was  of 
B 10.D2 type. Infected chimeras were slightly polycythemic (mean hematocrit ~- 54%) 
and  reticuloeytotic  (mean  reticulocyte count  =  12%)  4  wk after  infection.  At  that 
time,  28%  of the total hemoglobin and  <10%  of the newly synthesized hemoglobin 
was  of B10.D2  type.  The  fall in  the proportion  of B10.D2  hemoglobin in  infected 
animals  is consistent  with  decreased synthesis of B10.D2  hemoglobin  in  the  weeks 
after infection. Similar results are shown for the DBA/2 chimeras. 
As noted above, some uninfected chimeras followed from 2 to 4 mo after transplan- 
tation also showed  a  decrease in the proportion of B10.D2  hemoglobin.  This raised 
the  possibility that  Friend  virus might  simply accelerate a  normal  shift  to  DBA/2 
hemoglobin  in  the  chimeras,  perhaps  by  increasing  the  rate  of erythropoiesis  or 
shortening erythrocyte survival nonspecifically (28). To test whether other agents that 
shorten  erythrocyte  survival  and  stimulate  erythropoiesis would  accelerate  a  shift 
toward  DBA/2  hemoglobin,  groups  of chimeras  were  given  repeated  injections of 
PHZ.  PHZ  causes  acute  hemolysis  with  a  compensatory  increase  in  the  rate  of 
erythropoiesis. The dose and schedule of PHZ administration were chosen to produce 
at least as much  stimulation of erythropoiesis, as estimated by reticulocyte count, as 
seen  in  Friend  virus-infected chimeras.  Tables  II and  III show  that  PHZ  does  not 
significantly  alter  the  proportional  rate  of  B10.D2  hemoglobin  synthesis  in  the 
chimeras  (compare  groups  I  and  II), whereas  Friend  virus dramatically reduces  it 
(groups III and IV). We conclude that  the effect of Friend virus infection is not  the 
result of a  general increase in the rate of erythrocytes synthesis or destruction. 
The results so far are consistent with B 10.D2 bone marrow remaining resistant to 
Friend  virus-stimulated, erythropoietin-independent erythropoiesis in  the  chimeras. 
In  such  infected  polycythemic  chimeras,  erythropoietin  would  be  expected  to  be 
suppressed (4,  5), and in the absence of erythropoietin, B10.D2  erythroid precursors 
might  not  be induced to differentiate. To test whether B10.D2  erythroid precursors 
remained  subject  to  normal  erythropoietic  stimulation  in  the  infected  chimeras, 
groups of infected animals were given PHZ after they had become polycythemic. As 132  FRIEND  VIRUS-STIMULATED  ERYTHROPOIESIS 
TABLE  II 
Effect of PHZ on Synthesis of Hbb s in  Uninfected and Infected B I O.D2 Bone Marrow Chimeras 
Number  Total hemo-  Newly synthe- 
Treatment group  of mice  Hematocrits  Reticulocytes  globin  sized hemo- 
globin 
%  %  % Hbb ~  % Hbb 8 
I.  Control  7  48 ±  2  2 +  2  39 ±  10  30 ±  5 
II.  PHZ  5  49±2  41±  13  33±7  32±7 
III.  FV-P (100 FFU)  3  49 ±  5  9 ±  6  32 +  9  19 ±  6* 
IV.  FV-P (1,000 FFU)  3  45 :tz  12  11 ±  3  40 +  12  8 ±  l~: 
V.  FV-P (100 FFU) +  PHZ  2 
FV-P (1,000 FFU) +  PHZ  1 
Before  After  Before  After  After  After 
PHZ  PHZ  PHZ  PHZ  PHZ  PHZ 
60±539±13  7±2  40±6  33±3  34±6§ 
B10.D2 mice were lethally irradiated and transplanted with a  h l  mixture of DBA/2 and B10.D2 bone 
marrow cells 2 mo before the start of the experiment. Hemoglobin was labeled in vivo by injecting 10 
#Ci  ~Fe  intravenously 2  d  before  the  final  bleeding.  Group  I,  control  chimeras;  group  II,  chimeras 
injected with 0.8 mg PHZ intraperitoneally on days 0, 4, 9, 12, 20, and 21, and bled on day 25; group III, 
chimeras infected with 100 FFU of FV-P on day 0 and bled on day 25; group IV, same as group III, but 
infected with  1,000  FFU  of FV-P;  group V,  two  chimeras infected with  100  FFU  and one chimera 
infected with 1,000 FFU of FV-P on day 0. These mice were bled on day 22 (before PHZ) and then given 
0.8 mg PHZ subcutaneously on days 22 and 23 and bled again on day 28 (after PHZ). Numbers in the 
table represent the mean ±  SD. 
* P <  0.05 compared with controls. 
P <  0.001 compared with controls. 
§ P <  0.05 compared with group III. 
TABLE  III 
Effect of PHZ on Synthesis of Hbb s in  Uninfected and Infected DBA/2  Bone Marrow Chimeras 
Number  Day  Hematocrits  Reticulo-  Total hemo-  Newly 
Treatment group  of mice  tested  cytes  globin  synthesized 
hemoglobin 
%  %  % Hbb*  % Hbb 8 
I.  Control  8  14  44 ±  7  4 ±  2  42 ±  9  36 +  8 
II.  PHZ  5  14  43±2  26+5  27±8  31+  7 
III.  FV-P  8  14  59±4  24+  7  29±4  11 ±  1" 
IV.  FV-P  4  23  61  ±  4  14 ±  7  21 ±  6  9 ±  2* 
V.  FV-P +  PHZ  6  23  35 ±  3  29 ±  7  22 ±  4  21 ±  4:[: 
DBA/2 mice were lethally irradiated and transplanted with a  h l  mixture of DBA/2 and B10.D2 bone 
marrow cells 2.5 mo before the start of the experiment. At the indicated times after infection (day 0) or 
after  the  start  of PHZ  administration  (day  0),  chimeras were  bled  (100  #1  from  the  tail  vein)  and 
reticulocytes were labeled in vitro with ~Fe. Group I, control chimeras; group II, chimeras given PHZ 
(0.8 mg) intraperitoneally on days 0,  1, 6, and  11; group III, eight chimeras infected with  1,000 FFU of 
FV-P on day 0; group IV, two mice from group III and two additional chimeras infected with 1,000 FFU 
of FV-P on day 0; group V, six mice from group III given PHZ (0.8 mg) subcutaneously on days 18,  19, 
and 20. Numbers in the table are mean ±  SD. 
* P <  0.00l compared with control group. 
:~ P <  0.001 compared with group IV. 
shown  in Tables  II  and  III  (group  V),  PHZ  treatment  of infected  plethoric  chimeras 
reduced  the  hematocrit  and  restored  synthesis  of B 10.D2  hemoglobin. 
In  most  uninfected  chimeras,  the  proportion  of newly  synthesized  hemoglobin  of 
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(Tables  I-III).  The  difference between  these  proportions  was  calculated  for each 
chimera. When the data from all chimeras were combined, the average difference was 
6.3  ±  1.4% (mean +_ SEM).  This number is significantly different from zero  (P < 
0.001). The fact that the proportion of total hemoglobin of B10.D2 type is slightly, 
but  significantly, greater than the proportion  of newly synthesized hemoglobin of 
B10.D2 type, suggests a  gradual decrease in the relative rate of synthesis of B10.D2 
hemoglobin. Such a decrease is consistent with the observation of a gradual fall in the 
proportion of B10.D2 hemoglobin in uninfected chimeras followed for 2-4 mo after 
transplantation (see above). 
In animals treated with PHZ, there is closer agreement between the proportion of 
newly synthesized hemoglobin of B 10.D2 type and the proportion of total hemoglobin 
of B10.D2  type (Tables II and III). The difference between these proportions was 
calculated for each chimera treated with PHZ. The average difference was found to 
be  1.0 ±  1.3% (mean ±  SEM), not significantly different from zero (P >  0.4).  This 
result is not surprising because PHZ causes massive hemolysis, destroying old eryth- 
rocytes; after PHZ treatment, nearly all of the hemoglobin present is newly synthe- 
sized. Hence, the proportion of total hemoglobin of B10.D2 type should be the same 
as the proportion of newly synthesized hemoglobin of B 10.D2 type. 
It  is  possible  that  PHZ  treatment  could  artifactually produce  close  agreement 
between the proportion of total and newly synthesized hemoglobin of B10.D2 type. 
This would be the case if PHZ increased the rate of iron exchange between hemoglobin 
molecules (for example, by increasing the amount of methemoglobin, a  species that 
facilitates iron  exchange)  (25,  29).  However,  this  possibility is  extremely unlikely 
because (a) PHZ treatment was always stopped several days before 59Fe labeling and 
preparation of hemolysates, (b) no increase in methemoglobin was detected (<1%) in 
blood samples from mice treated 2 d  earlier with PHZ, and  (c)  no increase in iron 
exchange  between  labeled  and  unlabeled  hemoglobins  was  observed  when  these 
hemoglobins were obtained from mice treated with PHZ (data not shown). 
Discussion 
The experiments reported here show that B10.D2 bone marrow remains resistant 
to Friend virus-stimulated erythropoiesis even when exposed to an amount of SFFV 
that, in the same chimeric animal, stimulates DBA/2 erythroid precursors. One may 
conclude that resistance to virus-stimulated erythropoiesis is an intrinsic property of 
B 10.D2 erythroid precursors. This, in turn, implies that B 10.D2 mice are resistant to 
Friend  virus-stimulated  erythropoiesis  for  reasons  other  than  poor  replication  of 
SFFV. 
The experimental results strongly suggest that DBA/2 erythroid precursors become 
independent of erythropoietin in the infected chimeras, because DBA/2 hemoglobin 
synthesis continues after the mice have become polycythemic. Previous experiments 
have  shown  that  erythropoietin,  the  physiological  regulator  of erythropoiesis,  is 
undetectable  in  polycythemic Friend  virus-infected mice  (4,  5).  Our  experiments 
suggest that B 10.D2 erythroid precursors remain under erythropoietin control because 
B10.D2  hemoglobin synthesis stops when infected chimeras become polycythemic, 
and starts again when the mice are made anemic with PHZ. However, the erythro- 
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erythropoietin levels were not  measured, and  PHZ may stimulate erythropoesis by 
mechanisms other than simply the release of erythropoietin. 
The  relationship  between  SFFV  replication  and  virus-stimulated  erythropoiesis 
may be quite complex on a cellular level. For example, it is possible that SFFV must 
infect erythroid precursors to induce them to differentiate in the absence of erythro- 
poietin. According to this hypothesis, if the Fv-2 r gene prevented SFFV from repli- 
cating in hemopoietic cells (15), it could block virus-stimulated erythropoiesis. On the 
other hand, it has also been suggested that the majority of SFFV produced in vivo 
may come from rapidly proliferating hemopoietic cells (16). By this hypothesis, if the 
primary effect of the Fv-2 ~ gene were to block virus-stimulated erythropoiesis, then 
poor SFFV replication in the animal would follow secondarily. To investigate these 
hypotheses, it will be important to determine whether B10.D2 hemopoietic cells in 
the chimeras are themselves infected with SFFV. 
The experimental results provide additional evidence that virus-stimulated eryth- 
ropoiesis is not mediated by erythropoietin, other humoral factors or cell-cell inter- 
actions that substitute for erythropoietin. If such mechanisms were involved in virus- 
stimulated  erythropoiesis,  they  would  be  expected  to  act  "in  trans"  on  B10.D2 
erythroid precursors in the chimeras, leading to apparent loss of resistance of B 10.D2 
bone marrow. This was not observed. Of course, the experiments do not rule out the 
possibility of erythropoietic factors or cell-cell interactions that do not operate across 
strain  barriers, or whose action might  be modified by SFFV infection of erythroid 
precursors. 
The experimental results raise  may questions about  the  nature  and  level of the 
block to B 10.D2 hemoglobin synthesis in the infected chimeras. Is terminal differen- 
tiation of B10.D2 erythroid precursors blocked merely by the absence of erythropoi- 
etin,  or  do  suppressive  factors  or  interactions  exist,  as  have  been  suggested  for 
inhibition of normal stem cells in patients with polycythemia vera (30)? Are B10.D2 
erythroid  precursors  increased  in  number  of the  bone  marrow  and/or  spleens  of 
infected chimeras? The latter might be suspected because DBA/2 erythroid precursors 
should be increased in number in the infected chimeras (31), and yet a large fraction 
of newly synthesized hemoglobin is of B10.D2 type after treatment with PHZ. The 
application of clonal assays of erythroid precursors to this system should help answer 
these questions. 
Because these experiments were done with strains of mice that differ at many loci, 
one cannot with assurance attribute the observed effects to particular genes such as 
Fv-2.  Thus,  although  it  might  be  tempting  to  relate  the  slow  increase  in  DBA/2 
hemoglobin in uninfected chimeras to Fv-2-controlled differences in rate of cycling of 
erythroid precursors  (17),  one cannot  rule out  effects due,  for example,  to  minor 
histocompatibility differences. Similarly, the  resistance of B10.D2 bone marrow to 
Friend virus-stimulated erythropoiesis in the chimeras could be due to other Friend 
virus  resistance  genes  in  the  B10  strain  background  (32,  33).  Experiments  using 
congenic strains differing only at Fv-2 and Hbb should clarify these points. 
Although the chimeras used in these experiments were susceptible to Friend virus- 
stimulated  erythropoiesis,  they  were  clearly  less  susceptible  than  nonirradiated 
DBA/2 controls. This was apparent in the low levels of polycythemia achieved after 
a substantial dose of SFFV, a reduced degree ofsplenomegaly in the infected chimeras, 
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(unpublished  observations). The relative resistance of the chimeras  to Friend  virus 
could  have been contributed  by the  B10.D2  bone marrow, because the  B10  back- 
ground carries genes that affect the immune response to Friend virus (32, 33). 
The  experimental  system  described  here  is  analogous  to  a  rare  "experiment  of 
nature": glucose 6-phosphate dehydrogenase (G6PD) heterozygous women with poly- 
cythemia vera. Elegant studies of two such women, who are "natural" chimeras for 
the  X  chromosome-coded  enzyme  G6PD,  show  that  erythropoietin-independent 
erythroid precursors are all of  one G6PD type, whereas some erythropoietin-dependent 
erythroid  precursors  carry  the  other  G6PD  type  (30).  These  studies  support  the 
hypothesis that polycythemia vera is a clonal disease and provide a way to study the 
interaction  between  the  "polycythemia" clone and  "normal" stem cells in  a  single 
host.  In  the  artificial  murine  chimeras  described  here,  erythropoietin-independent 
erythroid precursors carry one hemoglobin type, whereas seemingly erythropoietin- 
dependent erythroid precursors carry the other hemoglobin type. It should therefore 
be possible to do similar studies to investigate the interaction between "normal" and 
"diseased" erythroid precursors in these Friend virus-infected bone marrow chimeras. 
The animal system has obvious advantages in terms of reproducibility and manipul- 
ability compared with the rare human condition for which it serves as a  model. 
Summary 
Bone marrow chimeras were formed containing mixtures of DBA/2 (Fv-288, Hbb dd) 
and  B10.D2  (Fv-2  ~,  Hbb ~)  bone marrow.  When  these mice were infected with the 
polycythemia-inducing strain of Friend virus, erythropoiesis was stimulated, but the 
proportion of B 10.D2 hemoglobin fell rapidly and newly synthesized hemoglobin was 
essentially all of the DBA/2 type. The treatment of infected polycythemic chimeras 
with phenylhydrazine lowered the hematocrit and restored the synthesis of B10.D2 
hemoglobin.  These results  imply that  B10.D2  erythroid  precursors are intrinsically 
resistant to Friend virus-stimulated erythropoiesis. The experiments also suggest that 
virus-stimulated erythropoiesis is not  mediated  by a  factor or cell-cell  interactions, 
unless such factors or interactions do not act across strain barriers. 
The authors wish to thank Ms. Audrey Gibson for assistance in preparation of the manuscript. 
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